Company cuts 9,000 jobs and lowers profit forecast as Wegovy sales slow. Q3 operating profit down 30% on competition ...

Over 24% of Indian adults across all states are now considered overweight or obese with more than 12.5 million children under ...

The Danish drugmaker has gone from steady to chaotic. Its fight with Pfizer to acquire Metsera is getting more heated.

The latest of those is a bid valued at up to $10 billion for U.S. obesity-drug developer Metsera, up from a previous $9 billion offer it originally made, as it tries to usurp an already agree-on deal ...

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

New research shows that a new weight-loss drug called MariTide might offer a powerful alternative to current weekly ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Many doctors and patients came to believe the rise in obesity may be all but biologically inescapable, despite the grave ...

Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems ...

A new Gallup poll indicates that the obesity rate among U.S. adults has declined over the past three years as the number of ...